(Q54438048)

29 May 2018

title

[Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery]. (English)

1 reference

29 May 2018

1 reference

M Mayer

1

1 reference

29 May 2018

J Brand

series ordinal

2

1 reference

29 May 2018

D Schlenkhoff

series ordinal

3

1 reference

29 May 2018

W Opferkuch

series ordinal

4

1 reference

29 May 2018

language of work or name

German

0 references

publication date

1 January 1986

1 reference

29 May 2018

published in

Infection

1 reference

29 May 2018

volume

14 Suppl 2

1 reference

29 May 2018

page(s)

S160-3

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01647502

exact match

0 references

cites work

In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01647502

Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)

21 January 2018

1 reference

12 December 2020

Simple screening method for gram-positive bacterial beta-lactam antibiotic tolerance on routine laboratory Bauer-Kirby antibiogram plates.

1 reference

12 December 2020

beta-Lactamase activity of renal dipeptidase against N-formimidoyl-thienamycin

1 reference

12 December 2020

A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives

1 reference

12 December 2020

Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin

1 reference

12 December 2020

[Hospital infections and problems of resistance today]

1 reference

12 December 2020

In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance

1 reference

12 December 2020

Impact of imipenem/cilastatin therapy on normal fecal flora.

1 reference

12 December 2020

Treatment of skin and soft tissue infections with imipenem/cilastatin.

1 reference

12 December 2020

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors

1 reference

12 December 2020

Antibiotic-resistant staphylococci in a teaching hospital.

1 reference

12 December 2020

The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.

1 reference

12 December 2020

Open trial of imipenem/cilastatin therapy for serious bacterial infections.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01647502

1 reference

29 May 2018

1 reference

29 May 2018